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report that the simple elimination of the amino acid valine from the diets of healthy mice leads to depletion of native HSCs, pointing to a less toxic way to condition the body for bonemarrow transplantation.
A wealth of evidence 2 has demonstrated that non-haematopoietic cells in the bone marrow have essential roles in maintaining the health of HSCs, either by direct contact or through the secretion of soluble factors. Taya Figure 1 | Reducing toxicity in bone-marrow transplantation. a, In conventional bone-marrow transplantation in mice, radiation is used to ablate haematopoietic stem cells (HSCs), but this treatment also damages the niche in which the HSCs grow in close proximity to small bone-marrow blood vessels called sinusoids. Healthy donor HSCs are then transplanted into the bone marrow, and completely reconstitute the blood. This approach is effective in replacing the recipient's blood-forming system, but causes infertility and diminished lifespan. b, Taya et al. 1 describe an alternative approach. Depletion of the amino acid valine from the diet causes a degree of native HSC depletion and dysfunction that enables the engraftment of healthy donor HSCs, while apparently preserving the niche. The engrafted HSCs partially contribute to the blood-forming system, and some recipient HSCs recover when mice are put back on a normal diet. Mice transplanted using this strategy have normal lifespans and fertility. birth when Piezo2 is deleted in the dorsal-root and jugular neurons? The lungs of mammals undergo major changes at birth, as the liquid that filled them in the womb is replaced by air. The defects must arise from loss of some form of mechanoreception, but what precisely Piezo2 senses during these drastic alterations, and which of the two types of neuron normally conveys this information, remains to be defined.
Second, what is the role of the Piezo2-expressing neuroepithelial cell bodies in the lung? Nonomura and colleagues showed that these cells are contacted by afferents from neurons that also express or have expressed Piezo2. As such, they speculate that the neuroepithelial cell bodies sense lung inflation, but direct evidence for this supposition remains to be found.
Third, the current study did not investigate whether the P2ry1-expressing neuronswhich express Piezo2 (ref. 4) -are the ones that mediate the lung stretch response in adult mice. The genetically engineered mice needed to perform this experiment are available. If it is Piezo2 in the P2ry1-expressing neurons that mediates the stretch response, the story will have come full circle. If not, the reality is more complex, and merits further exploration.
Finally, we still lack knowledge about the way in which Piezo2 senses the forces exerted by lung inflation. In other systems, tension in the lipid bilayer of the cell membrane is thought to activate mechanosensitive ion channels, but whether this is true for the Piezo channels is not known 5 . A mechanistic understanding of this process would help to reveal how airway tension is transduced into nerve activity.
Defective airway mechanotransduction might be a contributing factor in respiratory diseases. For example, a blunted HeringBreuer reflex has been reported in patients with chronic obstructive pulmonary disease 6 and in an animal model of a disease called lung fibrosis, in which lung tissue becomes thickened, stiff and scarred 7 . There is also evidence to suggest that vagal innervation of the lungs is crucial for the establishment of adequate breathing at birth, when expansion of the newborn lung leads to huge pressure changes 8 . By providing insight into the mechanisms involved in the lung's stretch response, Nonomura and colleagues' study could lead to a better understanding of the role of this crucial response in disease. ■ 
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STEM CELLS
Valine starvation leads to a hungry niche
The haematopoietic stem cells that rejuvenate blood depend on a dietary source of the amino acid valine -a finding that has been exploited to reduce the toxicity of bone-marrow transplantation in mice. factors within the HSC niche, they might identify a vulnerability that could be exploited in bone-marrow transplantation. Tipped off by a paper from the 1940s, which reported that blood-forming cells in the bone marrow are particularly sensitive to protein deprivation 3 , the authors observed marked enrichment of soluble amino acids in the bone marrow compared with peripheral blood, and found that non-haematopoietic cells in the bone marrow release many amino acids.
On the basis of this finding, the researchers asked which, if any, of the 20 amino acids might be required for HSC function. They withheld individual amino acids from HSCs in vitro one by one, and found that valine and cysteine were required for HSC growth.
Valine, but not cysteine, is an 'essential' amino acid -there are no metabolic pathways that synthesize valine in humans or mice. Taya et al. therefore investigated the effects of dietary valine restriction on blood formation in vivo. They fed healthy mice a valine-free diet for four weeks, and found that the numbers of white blood cells, red blood cells and HSCs decreased during this period. Next, the authors gauged the fitness of HSCs from valine-deprived mice by measuring the cells' ability to compete with normal HSCs when engrafted into recipients that had been conditioned with radiation. The authors found that HSCs purified from valine-deprived mice performed poorly in this assay.
Because valine-deprived HSCs seem to function poorly, the researchers asked whether valine deprivation could impair native HSCs to an extent that would allow engraftment of donor HSCs -in essence, they tested the ability of valine deprivation alone to condition a recipient for a transplant. The researchers fed mice a valine-depleted diet for two weeks, then infused the animals with healthy donor HSCs before gradually returning recipients to a complete diet. Twelve weeks after the transplant, about 10-15% of mature blood cells in recipient mice were derived from donor HSCs, whereas there was no detectable donor HSC engraftment in recipients fed a complete diet. Importantly, mice transplanted following valine deprivation avoided the poor growth, reduced lifespan and infertility that followed conditioning by irradiation (Fig. 1) .
Finally, Taya et al. performed analogous experiments using human cells. They found that human HSCs require not only valine but also another essential amino acid, leucine, for growth in culture and for maintenance when engrafted into mice that have a compromised immune system.
Overall, this study shows that simple depletion of a key dietary factor can profoundly impair HSC function and permit engraftment of healthy donor HSCs. These findings provide an alternative strategy for conditioning that could prove useful in studies of HSC biology, because standard approaches for bone-marrow transplantation in model organisms use irradiation, which disrupts the HSC niche 4 . Furthermore, the data beg the tantalizing question of how amino-acid depletion might be leveraged to lower the toxicity of human bone-marrow transplants.
But we should note that, relative to techniques that use irradiation, valine depletion in transplant recipients has so far achieved only a low level of repopulation by donor HSCs. This would be adequate for treating some blood disorders, such as β-thalassaemia, but not all. Furthermore, the utility of valine or leucine depletion in bone-marrow transplants for leukaemia remains in question, because leukaemia stem cells have different metabolic requirements from normal HSCs (ref. 5) , and may not depend on these amino acids. It is also unclear how the third objective of conditioning -blunting the recipient's immune system -could be achieved with this method alone.
Mice deprived of valine for four weeks develop signs of protein malnutrition and, on reintroduction of valine, sometimes succumb to a toxic metabolic reaction called refeeding syndrome. Perhaps an ideal approach to conditioning would combine a shorter period of valine deprivation with other emerging methods for non-toxic conditioning. These include the use of anti-HSC antibodies 6 and antibody-drug conjugates 7 to clear native HSCs, and modulation of the immune system by varying signalling through cytokine molecules to permit donor engraftment 8 . Minimizing the toxicity of conditioning regimens could render bone-marrow transplantation accessible to people with leukaemia, who often are too ill to receive conditioning by chemoradiation. Moreover, it could open up the possibility of using transplants to treat milder blood disorders, in which current chemoradiation produces more complications than the underlying disease. Only time will tell whether these non-toxic approaches live up to the promise they show in mice, by proving safe and effective in humans. ■ 
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